Sign In
Buy AIM
$0.732
-0.0947 (-11.46%)
At Close: Jun 03, 2026
AIM ImmunoTech Announces NYSE American Notice of Noncompliance With Minimum Stockholders' Equity Requirements
04:15pm, Friday, 20'th Jun 2025
NYSE American previously issued similar warning for same matter and issued the new notice because the deficiency remains as of March 31, 2025
AIM ImmunoTech Resumes Trading on NYSE American
08:55am, Tuesday, 17'th Jun 2025
Company trading under the ticker “AIM” NYSE American effective at the start of trading today, Tuesday, June 17th Company trading under the ticker “AIM” NYSE American effective at the start of
Nostra Terra shares tipped for +300% upside
08:46am, Monday, 16'th Jun 2025
Nostra Terra Oil and Gas Company PLC (AIM:NTOG, OTC:NTOGF) shares are tipped for more than 300% upside as it continues to deliver in its self-funded growth strategy, that's the view of analysts at SP
Seeing Machines lands deal with ‘autonomous driving car company'
05:27am, Monday, 16'th Jun 2025
Seeing Machines Ltd (AIM:SEE, OTC:SEEMF) has landed a US$1.2 million agreement with ‘a North American autonomous driving company', with the AIM-quoted firm supplying its backup-driver monitoring sys
AIM ImmunoTech Granted U.S. Patent Covering Methods of Manufacturing Therapeutic dsRNA, Including Ampligen®
08:30am, Thursday, 12'th Jun 2025
Patent portfolio now includes protection for manufacture, methods and compositions Provides AIM with patent protection for manufacturing Ampligen until 2041 OCALA, Fla., June 12, 2025 (GLOBE NEWSWIRE)
AIM ImmunoTech Announces NYSE American Removal of Trading Suspension
08:00am, Thursday, 12'th Jun 2025
Company expected to resume trading on the NYSE American on Tuesday, June 17, 2025 Company expected to resume trading on the NYSE American on Tuesday, June 17, 2025
AIM ImmunoTech Announces 1-for-100 Reverse Stock Split
04:15pm, Wednesday, 11'th Jun 2025
OCALA, Fla., June 11, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (OTC Pink: AIMID) (NYSE American: AIM) (“AIM” or the “Company”) today announced a reverse stock split (“Reverse Stock Split
Polarean's Xenon MRI technology to feature in over 30 studies at American Thoracic Society events
11:36am, Thursday, 15'th May 2025
Polarean Imaging PLC (AIM:POLX, OTC:PLLWF), the AIM-listed medical imaging company, will have its Xenon-based magnetic resonance imaging (MRI) technology showcased in more than 30 clinical studies at
Aimia Inc. (AIMFF) Q1 2025 Earnings Call Transcript
09:54am, Tuesday, 13'th May 2025
Aimia Inc. (OTCPK:AIMFF) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Joe Racanelli - Vice President of Investor Relations Rhys Summerton - Executive Chairman Steven L
OCALA, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (OTC Pink: AIMI) (“AIM” or the “Company”) today announced the presentation of clinical trial data involv
Zephyr Energy reports strong flow rates at Utah well, boosting Paradox project prospects
02:48am, Wednesday, 07'th May 2025
I could not be more pleased with the initial results from this latest production test - CEO Colin Harrington Zephyr Energy PLC (AIM:ZPHR, OTCQB:ZPHRF) has reported strong early results from a product
Mirriad shares crash 78% as cash crisis puts survival in doubt
04:39am, Thursday, 01'st May 2025
Shares in Mirriad Advertising PLC (AIM:MIRI, OTCQX:MMDDF) plummeted 78% on Thursday after the company warned it may soon run out of money and could enter administration within days unless fresh fundin
Seeing Machines posts rebound in automotive volumes as industry stabilises
02:59am, Thursday, 01'st May 2025
Seeing Machines Ltd (AIM:SEE, OTC:SEEMF), the driver monitoring technology group, reported an encouraging pick-up in production volumes for the third quarter of its financial year, following a broader
AIM ImmunoTech Announces Trading Under the Ticker AIMI on the Pink Open Market
01:26pm, Monday, 07'th Apr 2025
OCALA, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (“AIM” or the “Company”) (OTC Pink: AIMI) — an immuno-pharma company focused on the research and development of therapeuti
AIM ImmunoTech Announces NYSE American Notice of Delisting and Appeal
04:45pm, Friday, 04'th Apr 2025
OCALA, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (“AIM” or the “Company”) (NYSE American: AIM), an immuno-pharma company focused on the research and development of therapeut
